Accurate Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Accurate Wealth Management's BMY Position: Q3 2026 in Review
Accurate Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 2.3% in Q3 2026, buying an estimated $11.8K and bringing the position to 8,446 shares worth $479K. The position accounts for 0.04% of the portfolio, ranked #382.
Accurate Wealth Management first reported a position in BMY in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.91M in Q1 2022. 1,592 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Accurate Wealth Management held 8,446 shares of Bristol-Myers Squibb worth $479K as of Q3 2026.
- Accurate Wealth Management bought 187 Bristol-Myers Squibb shares in Q3 2026, an estimated $11.8K.
- Bristol-Myers Squibb made up 0.04% of Accurate Wealth Management's portfolio in Q3 2026, its #382 holding.
- Accurate Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 21 quarters since.
- Accurate Wealth Management's Bristol-Myers Squibb position peaked at $1.91M in Q1 2022.
- 1,592 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Accurate Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.